World of DTC Marketing
AUGUST 15, 2022
The great resignation has not affected pharma because the jobs within the industry pay very well and most positions and employees like the benefit of having a steady job with good money. However, some pharma companies are having problems filling open positions, and when they do, they often find it wasn’t a good fit. Here are some things to consider to ensure you’re hiring good people.
pharmaphorum
AUGUST 15, 2022
The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna’s mRNA-1273.214 shot. The new vaccine is an updated version of Moderna’s widely-use Spikevax vaccine, which includes sequences from the original Wuhan strain of SARS-CoV-2, as well as from the Omicron BA.1 subvariant.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medgadget
AUGUST 15, 2022
Researchers at Nanchang University in China developed a photodynamic hydrogel treatment for teeth that disrupts bacterial biofilms, helps to prevent cavities, and whitens teeth. The gel is applied to the teeth and is then activated using green light, which is less harsh on nearby skin than the high intensity blue light that is sometimes used for teeth whitening procedures.
European Pharmaceutical Review
AUGUST 15, 2022
Research suggests copper (Cu) and silver (Ag) coated surfaces display significant differences in antiviral properties and that while copper is effective at reducing Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2; the cause of COVID-19) transmission, silver is not. As a result of corrosion, both copper and silver release positively charged ions into their environment, which can prevent bacterial growth or kill off the cells completely.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Legacy MEDSearch
AUGUST 15, 2022
ClearPoint Neuro, Inc., a global therapy-enabling platform company providing navigation and delivery to the brain, announced it has received 510(k) clearance for its ClearPoint Maestro Brain00 Model. Maestro is intended for automatic labeling, visualization, volumetric and shape quantification of segmentable brain structures from a set of MRI images.
MedCity News
AUGUST 15, 2022
Healthpilot uses an AI-driven platform to help consumers determine what Medicare plan is best for them. On the startup’s website, users can input their location, physicians, prescriptions, pharmacies and what benefits they want, and the algorithm will recommend the plan it believes is most cost-effective.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 15, 2022
The wet form of age-related macular degeneration (AMD) is currently treated with eye drugs that are blockbuster sellers. Opthea Limited is developing a wet AMD drug that goes after different targets and the biotech struck a pair of financing deals that provide it with the cash for pivotal tests that could show how well its approach works.
PharmExec
AUGUST 15, 2022
Tilton will bring together Ruder Finn's extensive social and digital capabilities under the healthcare banner and be responsible for the strategic development and execution of digital programs for clients across product, policy, and corporate healthcare communications.
MedCity News
AUGUST 15, 2022
Neenah, Wisconsin-based health system ThedaCare announced it is investing $3 million into Qventus, a SaaS company that uses artificial intelligence to automate care operations. The health system will collaborate with Qventus to develop new products, as well as support the company in expanding its technology to additional hospitals across the country.
MedReps
AUGUST 15, 2022
Why are negotiating skills important? After you’ve learned how to negotiate, the answer to this question will be obvious. Until then, you need to understand that in medical sales and many aspects of business, people will always look out for themselves. Even the friendliest customer is trying to maximize their budget and feel like they’ve won. That means if they can buy your product for less, they’ll do it. .
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
AUGUST 15, 2022
Gilead Sciences said it has statistically significant and clinically meaningful data from a pivotal test of its cancer drug, Trodelvy, in the most common type of breast cancer. While detailed data remain undisclosed, the company said it has filed a submission with the FDA seeking to expand the drug’s approval to include this larger group of breast cancer patients.
pharmaphorum
AUGUST 15, 2022
In the space of a couple of months, Gilead Sciences’ Trodelvy impact on overall survival (OS) in the TROPICs-02 trial in advanced breast cancer has gone from a trend to a statistically significant improvement, raising its chances of approval in a new indication. At this year’s ASCO congress, the Trop2-targeting antibody-drug conjugate (ADC) was found to improve progression-free survival significantly in in patients with hormone receptor-positive, HER2-negative metastatic breast cance
MedCity News
AUGUST 15, 2022
Digital physical therapy services, long offered in Europe but are new in the U.S., offer American patients a new way to access PT and have given U.S. health plans a way to reduce costs compared to conventional PT.
PharmExec
AUGUST 15, 2022
Pharma loses battle to block price negotiations, but implementation faces many challenges.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
MedCity News
AUGUST 15, 2022
The survey reported 35% of respondents already offer travel and lodging benefits for abortions, while 16% plan to in 2023 and 21% are considering it. .
PharmaTimes
AUGUST 15, 2022
Study results show the candidate has demonstrated significantly higher antibodies against Omicron
MedCity News
AUGUST 15, 2022
AMD in particular impacts as many as 11 million Americans. About 15% of those affected have neovascular or wet AMD. It’s a devastating disease that can lead to irreversible vision loss.
PharmaTimes
AUGUST 15, 2022
Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
MedCity News
AUGUST 15, 2022
Nanopath, a women’s health diagnostics startup, recently closed a $10 million in Series A funding round. The company will use the money to develop and commercialize its platform, which aims to diagnose women’s pelvic and gynecologic infections within minutes.
PharmExec
AUGUST 15, 2022
Imaging is an integral part of many clinical studies, particularly in the fields of oncology and ophthalmology. Learn why imaging and centralized review are essential for clinical trials, how to address challenges that arise in these studies, and the advantages of partnering with MERIT in this video.
MedCity News
AUGUST 15, 2022
Many have celebrated the historic strides in healthcare made in the recent Inflation Reduction Act […].
Pharmaceutical Technology
AUGUST 15, 2022
It is no secret that Canada boasts a strong and competitive life sciences sector. The country has a long history of leadership and innovation in this field, from the discovery of stem cells and insulin to the invention of the world’s first pacemaker and much more. Within Canada, one province has often stood out as the place to be for cutting-edge life sciences innovation.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
PharmaVoice
AUGUST 15, 2022
Analysts are watching how cultural and political debates around reproductive rights may impact HRA Pharma's OTC birth control application.
PharmaTech
AUGUST 15, 2022
What actions can we as manufacturers take to make a difference to sustainability without disrupting the supply of our life-saving medicines?
Pharmacy Times
AUGUST 15, 2022
Treatment with biologic disease-modifying antirheumatic drugs associated with a higher overall risk, incidence, and recurrence of herpes zoster for patients with rheumatoid arthritis.
PharmaTech
AUGUST 15, 2022
A case study discussing why post-approval changes present a very low risk, and therefore can be downgraded from a prior-approval to a notification after implementation and managed in the PQS with immediate implementation effect.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmacy Times
AUGUST 15, 2022
Although some physicians caution against menopausal hormone therapy, a new study finds that it does not lead to breast cancer recurrence or mortality.
PharmaTech
AUGUST 15, 2022
The Faustovirus Capping Enzyme launched by New England Biolabs is designed to increase capping efficiency and scalability of mRNA manufacturing workflows.
Pharmacy Times
AUGUST 15, 2022
The company-sponsored phase 1/2 study evaluates a cryopreserved, readily available formulation for the treatment of follicular and diffuse large B cell lymphomas.
PharmaTech
AUGUST 15, 2022
The United Kingdom has approved Moderna’s bivalent COVID-19 vaccine, which targets the original variant and Omicron.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
281 
Let's personalize your content